Objectives: The aim of this study was to assess the outcome of arrhythmogenic right
ventricular dysplasia/cardiomyopathy (ARVD/C) patients treated with an implantable
cardioverter-defibrillator (ICD). Background: Arrhythmogenic right ventricular dysplasia/
cardiomyopathy is associated with tachyarrhythmia and an increased risk of sudden death.
Methods: This study included 42 ARVD/C patients with ICDs (52% male, age 6 to 69 years,
median 37 years) followed at our center. Results: Mean follow-up was 42±26 months (range …

Purpose Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a progressive
cardiomyopathy characterized by myocardial atrophy and fibro-fatty replacement of the right
ventricle (RV) and ventricular tachyarrhythmias in young patients. Our aim was to evaluate
clinical course and electronic parameters in patients with implantable cardioverter-
defibrillator (ICD) and ARVC, during long-term follow-up. Methods and results We report on
12 patients with ARVC (mean age 40±13 years) who were treated with ICD implantation in …